Indication:
Chronic bronchitis
Approved by FDA on December 20,1995
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Ceftibuten URTI, LRTI,UTI June 1988
Adverse Reaction:
Refer Cephalosporins
Contra-Indications:
Refer Cephalosporins
Dosages/ Overdosage Etc:
Approved by FDA on December 20,1995
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Ceftibuten URTI, LRTI,UTI June 1988
Indications:
Chronic bronchitis
Dosage:
Adults- max daily dose 400mg daily for 10 days Children- 9mg/kg daily for 10 days
Patient Information:
Refer Cephalosporins
Pharmacology/ Pharmacokinetics:
Refer Cephalosporins
Interaction with Food:
Capsule-May be taken with or without food
Suspension- take 2 hour before or 1 hour after meals
Pregnancy and lactation:
Refer Cephalosporins